Table
Maculopapular skin eruptions are characterized by an erythematous maculopapular rash coinciding temporally with the administration of a drug in the absence of underlying conditions unless it progresses to severe forms which are associated with extensive skin or mucosal involvement. A large number of drugs have been attributed to give rise to such eruptions. It is also one of the most common dermatologic manifestations in certain viral exanthems which are characterized by the prototypic morbilliform/maculopapular rash with or without an exanthem. Maculopapular rash is a common symptom in day-to-day clinical practice, and a large number of consultations and references are attributable to it. However, drugs initiated for the treatment of underlying infections can be a cause of a maculopapular eruption. In such a setting, it is a diagnostic dilemma to differentiate between the two. Table 1 enlists differences between the two so as to help physicians to differentiate between the two. A generalized eruption of erythematous macules and papules associated with systemic infection, often accompanied by fever and lymphadenopathy Epidemiology Adulthood, increased incidence in HIV-positive population and women [2] Childhood, no particular sex predilection [3, 4] Etiology Numerous drugs have been implicated such as antibiotics (most commonly beta-lactams, sulphonamides, cephalosporins, quinolones, tetracyclines), anticonvulsants (phenytoin, carbamazepine, lamotrigine), NSAIDs, and allopurinol are common culprits. Antitubercular drugs such as ethambutol and pyrazinamide, antiretroviral agents such as protease inhibitors, emtricitabine, and tenofovir [5] Measles (Paramyxoviridae), rubella (Togaviridae), erythema infectiosum (Parvoviridae), Roseola Infantum HHV Types 6 and 7 belonging to the Roseolovirus genus, infectious mononucleosis by EBV or CMV. Rare etiologic agents are nonpolio enteroviruses, rhinovirus, adenovirus, parainfluenza virus, respiratory syncytial virus, and influenza virus [3, 4] Mechanism Maculopapular drug eruption is a T-cell-mediated delayed hypersensitivity (Type IV) type reaction [6] After the entry of virus into the body, it incubates and enters the viremic phase where there occurs dissemination of viral particles to all tissues of the body. The exanthema occurs as a result of perivascular inflammatory reaction to the virus in the skin Onset of rash
Maculopapular Drug Eruption versus Maculopapular Viral Exanthem
The eruption usually begins within a week upto 10 days after intake of the offending drug [7] on the trunk and upper extremities and progresses caudally Prodromal symptoms such as fever, conjunctivitis, rhinorrhea, cough, pneumonia, otitis media in measles, headache, sore throat, and myalgia, arthralgia, in rubella, cephalocaudal distribution of maculopapular eruption in measles and rubella [3, 4] 
Temperature
Low-to-moderate grade fever may be present High-grade fever in erythema infectiosum, roseola infantum Low-grade fever in measles, rubella, EBV, and CMV infections [3, 4] 
Cutaneous manifestation
Erythematous maculopapular eruption appears on the trunk and upper extremities and then progresses caudally [ Figure 1 ]. It is usually symmetric and may get confluent and severe in dependent areas, such as the back. Facial involvement can be seen. In severe forms, the mucosae (oral, conjunctival, nasa, or anogenital) and skin appendages (hair and nails) may be involved. Petechiae and macular purpura may be noted occasionally on the legs secondary to hemostatic pressure Lesions are mostly pruritic Cephalocaudal distribution of maculopapular (morbilliform) eruption [ Figure 2 ] with sparing of palms and soles, may be associated with lymphadenopathy as in rubella or Koplik's spots over the buccal mucosa in measles Slapped cheek appearance in erythema infectiosum along with rash over proximal extremities, rarely petechial Appearance of maculopapular rash following intake of ampicillin/amoxicillin in suspected cases of infectious mononucleosis Characteristically the rash is nonpruritic Diagnosis
Diagnosis is clinical and requires a high index of suspicion. Temporal correlation with drug intake will be found. Appearance of rash on drug re-challenge is characteristic Diagnosis requires correlation of clinical findings with special relevance to morphology, distribution, and time course of eruptions with associated systemic findings In addition, laboratory parameters and ELISA for IgM antibody against the respective viruses aid in diagnosis [3, 4] 
Maculopapular drug eruption Maculopapular viral exanthem

Laboratory investigations
Occasional derangement of liver function tests and raised eosinophil counts may be associated Histopathology from the maculopapular lesions shows focal spongiosis, with underlying focal-vacuolar interface changes, occasional necrotic keratinocytes, superficial and deep perivascular lymphocytes, and eosinophils [8] Skin intradermal/prick tests may show immediate reactions to penicillin and a few other drugs Patch tests using the suspected drugs should be done to confirm the diagnosis [7] Serologic investigations show elevated blood counts, lymphocytosis or lymphocytopenia, atypical lymphocytes, thrombocytopenia, [9] transient aplastic anemia in parvovirus B19 infection [10] Histopathology features in viral exanthemata include a superficial perivascular infiltrate of lymphocytes without associated epidermal changes, a superficial-vacuolar interface dermatitis, sometimes associated with eosinophils and neutrophils, a lichenoid dermatitis, and a mild spongiotic dermatitis. All these patterns may also be encountered in drug eruptions [11] Serum ELISA for IgM antibody against the viral antigen can be detected in the initial few days 
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